Seelos Therapeutics to Participate in the 2021 Jefferies Virtual Healthcare Conference
Seelos Therapeutics, Inc. a clinical-stage biopharmaceutical company focused on the development of therapies for central nervous system disorders and rare diseases, today announced that it will participate in the 2021 Jefferies Virtual Healthcare Conference, June 1-4, 2021 . Raj Mehra, Ph.D., Chairman and CEO, will present on Thursday, June 3rd at 10:30am ET and host 1×1 meetings. Presentation webcast registration …
Seelos Therapeutics, Inc. (Nasdaq: SEEL), a clinical-stage biopharmaceutical company focused on the development of therapies for central nervous system disorders and rare diseases, today announced that it will participate in the 2021 Jefferies Virtual Healthcare Conference, June 1-4, 2021 .